Use of next-generation sequencing to investigate foot-and ... · Donald King...

19
Donald King [email protected] OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing to investigate foot-and-mouth disease virus transmission

Transcript of Use of next-generation sequencing to investigate foot-and ... · Donald King...

Page 1: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Donald King [email protected]

OIE Reference Laboratories for FMD and SVD

Use of next-generation sequencing to investigate

foot-and-mouth disease virus transmission

Page 2: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Reference Laboratories at the Pirbright Institute

New high-containment laboratory will open in 2014/15

Page 3: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Foot-and-Mouth Disease Virus

• Family Picornaviridae, genus Aphthovirus • Causes a highly contagious disease of cloven-hoofed

livestock Cattle, sheep, goats and pigs

• + sense ss RNA genome ~8300nt • 7 Serotypes (O; A; C; SAT1; 2; 3 and Asia-1)

including numerous subtypes VP1 sequence data widely used for strain characterisation

L 2A 3CPrimary cleavages

Poly(C)

L 1A 1B 1C 1D 2A 2B 2C 3A 3B 3C 3D

Secondary cleavages 1B/RNA? 3C 3C 3C 3C 3C 3C

Kilobases

0 1 2 3 4 5 6 7 8

ProteaseCarboxy-terminalself-cleaving

ProteaseCapsid NTP binding* Polymerase

Genome-linked(VPg)

Membrane-binding

VP4 VP2 VP3 VP1VPG

5’UTR

AAA (n)

3’UTR

Page 4: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

• Multiple virus serotypes/topotypes/strains

• Monitoring global patterns of virus distribution Tracing sources of outbreaks

Early recognition of the emergence of new lineages

• Antigenic prediction and vaccine selection

Why do we sequence FMDV?.........

Page 5: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Example: Molecular Epidemiology O/SKR/1/2011

O/SKR/3/2011

O/Paju/SKR/2010 (NVRQS)

O/SKR/13/2010

O/SKR/7/2010

O/SKR/10/2010

O/SKR/12/2010 (KC438373)

O/Yeoncheon/SKR/2010 (NVRQS)

O/Yangju/SKR/2010 (NVRQS)

O/SKR/8/2011

O/CHA/31/2010* (JF792356)

O/JPN/MZ1/2010 (AB618503)

O/HKN/14/2010

O/HKN/7/2010 (JQ070303)

O/HKN/8/2010

O/HKN/13/2010

O/HKN/15/2010

O/HKN/9/2010 (JQ070304)

O/HKN/10/2010

O/HKN/11/2010

O/HKN/12/2010

O/33-P/CHA/2010 (JQ973889)

O/SKR/4/2010 (JQ070320)

O/KOR/1/2010* (HM143846)

O/GZ/CHA/2010 (JN998086)

O/VN/LC169/2009 (HM055510)

O/MY/CHA/2010 (HQ652079)

O/NC/CHA/2010 (HQ652080)

O/GSLX/CHA/2010 (JQ900581)

O/VN/YB10/2010 (HQ260720)

O/VIT/NCVD-8/2010 (NVRQS)

O/VN/YB08/2010 (HQ260718)

O/VIT/NCVD-9/2010 (NVRQS)

O/VN/YB09/2010 (HQ260719)

O/TAI/22/2009 (HQ116269)

O/VIT/NCVD-19/2010 (NVRQS)

O/VIT/NCVD-20/2010 (NVRQS)

O/GZ-MT/CHA/2013 (KJ646655)

O/Primorskiy/RUS/2014 (ARRIAH)

O/SKR/6/2014

O/SKR/01/2014* (APQA)

O/MYA/7/98 (DQ164925)

Mya-98

O/TAI/189/87* (TRRL)

Cam-94

SEA

WA

EA-1

EA-4

EA-3

EA-2

ME-SA

EURO-SA

ISA-2

ISA-1

CATHAY

100100

100

100

99

100

99

8979

77

83

86

100

98

99

96

98

86

97

100

85

82

75

74

89

85

86

80

84

0.02

• July 2014: FMD cases in Rep. of Korea

• FMD virus closely related to recent outbreaks in the Eastern part of the Russian Federation

• Appears to be a separate introduction into South Korea from cases in 2010-11

Page 6: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Limitations of VP1 data

• VP1 sequences can be used to provide evidence to support transboundary movements of FMDV

• Useful for regional and country-level epidemiology

• VP1 not typically useful to resolve transmission trees within outbreak clusters

• Can we use full genome sequence data to increase the resolution of analysis and trace the spread of FMDV during an outbreak?

• Sequencing improvements make rapid full-genome sequencing achievable Sanger methods NGS approaches

Page 7: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Complete genome sequencing work:

Caroline Wright

Guido König

Begoña Valdazo- González

Dan Haydon

Eleanor Cottam

Nick Knowles

Marco Morelli

Richard Orton

Grace Logan

Graham Freimanis

David King

Kasia Bankowska

Antonello Di-nardo

Müge Fırat-Saraç

Faizah Hamid

Jemma Wadsworth

Ack

no

wle

dge

me

nts

:

Page 8: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Cottam et al., 2006, J. Virol

Increased number of informative sites Retrospective analysis of the 2001 outbreak in the UK

Genome position

2A

2B 2C 3A 3B 3C 3D VP4 VP2 VP3 VP1 AAA (n) L

0 8000

• Analysis of 23 complete genome sequences (consensus) • 197 sites with nt substitutions

Page 9: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

IAH2

IAH1

AY593815

IP2b

IP2c

IP3c

IP4b

IP3b

IP5

IP6b

IP1b(1)

IP1b(2)

IP7

MAH IP8

Farm-to-farm level resolution

• Discriminates between viruses recovered from individual farms Data was provided rapidly (in real-time) to support UK eradication

programme Provided evidence for the existence of farms with undisclosed

infection

• Full genome sequences can also resolve transmission events (direct and indirect contact) in individual animals

Cottam et al 2008 PLoS Pathogens

TCS representation of sequences recovered from farms (UK 2007)

Sequenced virus Un-sampled intermediate

Juleff et al., (2013) J. Gen. Virol.

Page 10: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

• High error rate of the RNA polymerase

• Viruses exist as a mixture of closely related sequences within cells

• Sequencing methods can dissect population diversity within samples

• Results will improve our understanding of the mechanisms that drive the evolution of FMDV

Beyond the consensus:

Population diversityX X X

X XXXX

XXXX X

XX X

X XXX

Consensus

Sequence

Page 11: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

At depth “beyond the consensus”:

• To dissect the viral mixtures “quasispecies” present in a sample

• Evolutionary processes of RNA viruses at the finest scale

At the consensus level:

• Generate lots of viral sequences in a relatively short time

• Exploit multiplex format (unique indexes)

• Pathogen discovery: recognition of unique signatures association with uncharacterised (or unexpected) pathogens

• RNAseq – mRNA transcript analysis

Potential advantages and uses of NGS

Page 12: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Only the best quality reads (50nt) used • 7,190,884 ⋙ 2,828,554 A (run 1) • 10,116,147 ⋙ 8,969,902 B (run 2)

Raw data

Run 1

Run 2

Data used

Wright et al 2011 J. Virol.

Pilot expt: coverage generated from NGS:

Samples: 1. Inoculum 2. Back right foot lesion (BRF) 3. Front left foot lesion (FLF)

Page 13: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

KEY: AGCT

Evolution of a cell culture adapted virus Codon changes in cattle:

VP356 VP360

Glycine to Aspartic Acid

GAC

Arginine to Cysteine TGC

Arginine to

Histidine CAC

78.1

21.9

93.2

6.8

100 100 100

66.5

33.5

% N

ucl

eoti

de

(FLF

)

89.7

10.3

85.6

14.4

100 100

74.1

25.9

100

% N

ucl

eoti

de

(BR

F)

100 100 100 100 100 100

% N

ucl

eoti

de

(In

oc)

Arginine Glycine

Wright et. al. 2011 J. Virol.

INNOCULUM Heparan Sulphate

FLF FOOT LESION

Integrin

BRF FOOT LESION

integrin

Page 14: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Patterns of sub-consensus changes: C3 C1 C2

Transmission direction

C4

Lost

Drifting

Fixed

Morelli et al, (2013) Vet. Res.

Page 15: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

Global Phylogeography

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!( !(

!(

!(

!(

!(

!(!(

!(!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(!(

!(!(

!(

!(

!( !(

!(!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!( !(!(!(

!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(!( !(

!(

!(

!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(!( !(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(!(

!(!(

!(

!(

!(

!(

!(

!(!(!( !(

!(

!(

!(!(!(

!(!(

!(

!(

!(

!(

!(!(

!( !(

!(

!(!(

!(

!(

!(!(

!(

!(!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!( !(!(

!(

!(

!(

!(

!( !(

!(

!( !(!(

!(

!(

!(

!(!(!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(!(

!(

!(!(

!(

!(

!(!(!(!(!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!( !(!(

!(!(!(

!(

!(!(

!(!(

!(

!(!(

!(!(

!(!(

!(

!(

!( !(!(

!(!(

!(!(

!(!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!( !( !(!(

!(

!(

!( !(

!(

!(

!(!(!( !( !(

!(

!(

!(

!(

!(!(

!(

!(

!(

!( !(

!(!(

!(

!(

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(!(

!(

!(!(

!(

!(

!( !(!(

!(

!(!(

!(!(

!(

!(

!(

!(!( !(!(

!(

!(!(!(!(!(!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(!(

!(

!(

!( !(

!(

!(!(

!(!(

!(

!(

!(!(

!(

!(!(

!(!(

!(!(

!(

!(

!(!( !(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(

!(!(

!(

!(

!(

!(

!(!(!(

!( !(

!(

!(!(!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(!(

!( !(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(!( !(

!(

!(!(

!(

!( !(

!(

!( !(!(!(

!(

!(

!(

!( !(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!( !(!( !(

!(

!(!(!(

!(

!(

!(

!(

!(

!(!(

!(!(

!(!(

!( !(

!(

!(

!(

!( !(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!( !(!(!(

!(

!(

!(

!( !(

!(

!(

!(

!(

!(

!(

!(!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!( !(

!(

!(!(

!(

!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(!(!(

!(

!(

!(!(

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(!(

!(!(

!(!( !(

!(

!(!( !(

!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(

!(

!(

!(!(

!(!(

!(!( !(

!(

!(

!(!(!(

!(

!(

!(

!(!(

!( !(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!( !(!(!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!( !(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(

!( !(

!(!(

!(

!(

!(!(

!(

!(!(!(!(!(!(

!(

!(

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(!(!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(

!(!(

!(

!(

!(!(!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(!(

!(

!(!( !(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!( !(

!(!( !(!(

!(

!( !(!(

!(

!(

!(!(!(

!(!(

!(

!(!(

!(

!(!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(

!(!(

!(

!(

!(

!(

!(

!( !(

!(

!(

!(!(

!(

!(

!( !(!( !(!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(

!(!(!(

!(

!(

!(

!(

!(

!(!(

!(!(!(

!( !(

!(

!(

!(!(

!(!( !(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!( !(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(!( !(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!( !(!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(!(!( !(

!(!(

!(

!(

!(

!(

!(

!( !(

!(

!(!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(!(

!(!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!( !(!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(!( !(

!(

!(

!(!(!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(!( !(

!(

!(

!(!(

!(

!(

!(

!(!(!(!( !(

!(

!(

!(

!(

!(

!( !(

!(

!(!(!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(!(!(!(!(!( !(

!(

!(!(

!(

!(!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(

!(

!(!(

!(!(

!(

!(

!(!(!(!(!(

!(

!(

!(

!(

!(

!(

!( !(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(

!(

!(

!(

!(!(

!(

!(

!(

!(

!(!(

!(

!(

!(!(

!( !(!(

!(

!(

!(

!(

!(

!(

!(!(!(!(

!(!(

!(!(

!(

!(

!(!(

!(!(

!(

!(

!( !(!(!( !(

!(

!(!(!(

!(!(!(

!(

!(!(

!(

!(!(

!(!(

!( !(

!(

!(!(

!(

!(

!(

!(

!(!(!(

!(

!(!(!( !(!(

!( !(

!(!(!(!( !(

!(!(

!(!( !(!(

!(!(!(

!(

!(!(

!(

!(

!(

!(!(!(

!(

!(!(

!( !(!(

!(!(

!(

!(

!(!(

!(!(

!(

!( !(!(

!(

!(

!(

!(

!(!(

!(

!(!(

!(

!(

!(

!(!(

!(!(

!(

!(

!(

!(

!(

!(!(!(!(

!(

!(!( !(

!(!(!(

!(

!(

!(

!(

!(!(

!(

!(

!( !(

!(!(

!(

!(

!(!(!(!( !(

!( !(

!(!(!(!(!( !(!(

!(

!( !( !(!( !(

!(

!(

!(

!(!( !(!( !(

!(!(

!(!(!(!(!(

!(

!(!(!(

!(!(!( !(

!(

!(!(!(

!(!( !(!(!( !(!(

!(

!(!(!( !(!( !(!(!(!( !(!(!(

!(

!(

!(

!(!(

!(!(

!(!(

!(

!(!(!(

!(

!(!(!(

!(!(

!(!(!(!(!(

!(!(!(

!(

!(!( !(!( !(

!(!(

!(

!(

!( !(!(

!(

!(!(

!(

!(

!(

!(!(!(

!(!(

!(

!(!(!(!(!(

!(

!(

!(

!(

!(

intra-cellular dynamics

Population diversity

animal-animal transmission

farm-to-farm spread

Outbreak epidemiology

cell-to-cell infection

within host pathways

X X XX XX

XXXX

XX XX

X XX X

XX

5’ AAAA

•Sequence data for FMDV (VP1 ► complete genome ► deep-seq)

• These different scales are connected

• Underpinned by the error rate of the viral polymerase

• Field sampling, in-vivo and in-vitro experiments can only ever provide an incomplete picture of these processes

Joining the dots and scales

Orton et al., (2013) Phil Trans B

Page 16: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

EpiSeq project

Epi-Seq aims to exploit NGS technologies to: • Generate improved tools for use in real-time monitoring of

epidemics Results will bring novel insights into:

Epidemiology: monitor trans-boundary movements Evolutionary ecology: genetic determinants underpinning phenotypes

• Target important RNA/DNA viruses:

Causing epidemic disease (FMDV/AIV) Causing endemic disease (CSFV)

2 DNA viruses (ASFV and Poxviruses)

• Partners: Belgium, Germany, UK, Italy and Sweden and Denmark

Page 17: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

NGS (Illuminia) protocol for FMDV

Co

vera

ge/s

ite

Logan et al, (2014) BMC Genomics

• PCR-free protocol o Eliminates requirements for extensive primer panels

• Can be applied to “any” RNA virus with a poly (A) tail • High coverage suitable for consensus and deep-sequencing • Multiplexing (up to 96 samples/run) is possible

Page 18: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

• Future advances will deliver new platforms and increased capacity to generate sequence data

• Requires close relationships between molecular virologists, bioinformaticians and informaticians

Goals:

• Improved pipelines to reduce process-error and/or development of models to accommodate error in our data

• Approaches to translate genetic relationships into transmission trees (also using epidemiological data)

• Reliable (statistical) measures of the likelihood of transmission links

Summary and future priorities

Page 19: Use of next-generation sequencing to investigate foot-and ... · Donald King donald.king@pirbright.ac.uk OIE Reference Laboratories for FMD and SVD Use of next-generation sequencing

• The FMD Reference Laboratory

• Nick Juleff

• David Paton

• Jan Kim

• John Hammond

• Partners on EpiSeq project

Acknowledgements: Work supported by:

Photo courtesy of HDR Architecture, Inc.; © 2104 James Brittain